S. Maria Hospital, Terni Report issue

Academic/Hospital Phase 3

Organization Overview

First Clinical Trial
2009
NCT00869310
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2009

Timeline

NOW
  • Now

Alternative names

Oncology Division, S. Maria Hospital, Terni, Italy

Active Ingredients

Drugs in Phase 3 Trials (3)

aprepitant (Emend) (2 trials)

metoclopramide (reglan) (1 trial)

urea (2 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Vomiting (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 2
  • # of Trial APIs: 3